Mutation analysis of the PTEN gene in uveal melanoma cell lines
Nicole C. Naus
Department of Ophthalmology, Erasmus University Rotterdam, Rotterdam, the Netherlands
Department of Cell Biology and Genetics, Erasmus University Rotterdam, Rotterdam, the Netherlands
Search for more papers by this authorWieke Zuidervaart
Department of Ophthalmology, Erasmus University Rotterdam, Rotterdam, the Netherlands
Search for more papers by this authorNazik Rayman
Department of Cell Biology and Genetics, Erasmus University Rotterdam, Rotterdam, the Netherlands
Search for more papers by this authorRosalyn Slater
Department of Cell Biology and Genetics, Erasmus University Rotterdam, Rotterdam, the Netherlands
Department of Clinical Genetics, Erasmus University Rotterdam, Rotterdam, the Netherlands
Search for more papers by this authorEllen van Drunen
Department of Cell Biology and Genetics, Erasmus University Rotterdam, Rotterdam, the Netherlands
Search for more papers by this authorBruce Ksander
Schepens Eye Research Institute, Boston, Massachusetts, USA
Search for more papers by this authorGregorius P.M. Luyten
Department of Ophthalmology, Erasmus University Rotterdam, Rotterdam, the Netherlands
Search for more papers by this authorCorresponding Author
Annelies Klein
Department of Ophthalmology, Erasmus University Rotterdam, Rotterdam, the Netherlands
Department of Cell Biology and Genetics, Erasmus University Rotterdam, Rotterdam, the Netherlands
Departments of Ophthalmology and of Cell Biology and Genetics, Erasmus University Rotterdam, P.O. Box 1738, 3000 DR Rotterdam, the Netherlands. Fax: +31-10-4089468Search for more papers by this authorNicole C. Naus
Department of Ophthalmology, Erasmus University Rotterdam, Rotterdam, the Netherlands
Department of Cell Biology and Genetics, Erasmus University Rotterdam, Rotterdam, the Netherlands
Search for more papers by this authorWieke Zuidervaart
Department of Ophthalmology, Erasmus University Rotterdam, Rotterdam, the Netherlands
Search for more papers by this authorNazik Rayman
Department of Cell Biology and Genetics, Erasmus University Rotterdam, Rotterdam, the Netherlands
Search for more papers by this authorRosalyn Slater
Department of Cell Biology and Genetics, Erasmus University Rotterdam, Rotterdam, the Netherlands
Department of Clinical Genetics, Erasmus University Rotterdam, Rotterdam, the Netherlands
Search for more papers by this authorEllen van Drunen
Department of Cell Biology and Genetics, Erasmus University Rotterdam, Rotterdam, the Netherlands
Search for more papers by this authorBruce Ksander
Schepens Eye Research Institute, Boston, Massachusetts, USA
Search for more papers by this authorGregorius P.M. Luyten
Department of Ophthalmology, Erasmus University Rotterdam, Rotterdam, the Netherlands
Search for more papers by this authorCorresponding Author
Annelies Klein
Department of Ophthalmology, Erasmus University Rotterdam, Rotterdam, the Netherlands
Department of Cell Biology and Genetics, Erasmus University Rotterdam, Rotterdam, the Netherlands
Departments of Ophthalmology and of Cell Biology and Genetics, Erasmus University Rotterdam, P.O. Box 1738, 3000 DR Rotterdam, the Netherlands. Fax: +31-10-4089468Search for more papers by this author87:1<151::aid-ijc23>3.0.co;2-1.fp.png)
REFERENCES
- Cairns, P., Okami, K., Halachmi, S., Halachmi, N., Esteller, M., Herman, J.G., Jen, J., Isaacs, W.B., Bova, G.S. and Sidransky, D., Frequent inactivation of PTEN/MMAC1 in primary prostate cancer. Cancer Res., 57, 4997-5000 (1997).
- Chen, P.W., Murray, T.G., Salgaller, M.L. and Ksander, B.R., Expression of MAGE genes in ocular melanoma cell lines. J. Immunother., 20, 265-275 (1997).
- De Waard-Siebinga, I., Blom, D.J., Griffioen, M., Schrier, P.I., Hoogendoorn, E., Beverstock, G., Danen, E.H. and Jager, M.J., Establishment and characterisation of a uveal-melanoma cell line. Int. J. Cancer, 62,, 155-161 (1995).
- Guldberg, P., Thor straten, P., Birck, A., Ahrenkiel, V., Kirkin, A.F. and Zeuthen, J., Disruption of the MMAC1/PTEN gene by deletion or mutation is a frequent event in malignant melanoma. Cancer Res., 57, 3660-3663 (1997).
- Hagemeijer, A., de Klein, A., Wijsman, J., Van meerten, E., de Greef, G.E. and Sacchi, N., Development of an interphase fluorescent in situ hybridization (FISH) test to detect t(8;21) in AML patients. Leukemia, 12, 96-101 (1998).
- Li, J. and 16 Others, PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science, 275, 1943-1947 (1997).
-
Luyten, G.P.,
Naus, N.C.,
Mooy, C.M.,
Hagemeijer, A.,
Kan-mitchell, J.,
Van drunen, E.,
Vuzevski, V.,
De jong, P.T. and
Luider, T.M.,
Establishment and characterisation of primary and metastatic uveal melanoma cell lines.
Int. J. Cancer,
66,
380-387
(1996).
10.1002/(SICI)1097-0215(19960503)66:3<380::AID-IJC19>3.0.CO;2-F CAS PubMed Web of Science® Google Scholar
- Marsh, D.J. and 24 Others, Mutation spectrum and genotype-phenotype analyses in Cowden disease and Bannayan-Zonana syndrome, two hamartoma syndromes with germline PTEN mutation. Hum. mol. Genet., 7, 507-515 (1998).
- Marshall, J.F., Rutherford, D.C., Happerfield, L., Hanby, A., Mccartney, A.C., Newton-bishop, J. and Hart, I.R., Comparative analysis of integrins in vitro and in vivo in uveal and cutaneous melanomas. Brit. J. Cancer, 77, 522-529 (1998).
- Mooy, C.M. and De Jong, P.T., Prognostic parameters in uveal melanoma: a review. Surv. Ophthalmol., 41, 215-228 (1996).
- Prescher, G., Bornfeld, N., Hirche, H., Horsthemke, B., Jockel, K.H. and Becher, R., Prognostic implications of monosomy 3 in uveal melanoma. Lancet, 347, 1222-1225 (1996).
- Singh, A.D., Croce, C.M., Wary, K.K., Shields, J.A., Donoso, L.A., Shields, C.L., Huebner, K. and Ohta, M., Familial uveal melanoma: absence of germline mutations involving the cyclin-dependent kinase-4 inhibitor gene (p16). Ophthalmic Genet., 17, 39-40 (1996).
-
Sisley, K.,
Rennie, I.G.,
Parsons, M.A.,
Jacques, R.,
Hammond, D.W.,
Bell, S.M.,
Potter, A.M. and
Rees, R.C.,
Abnormalities of chromosomes 3 and 8 in posterior uveal melanoma correlate with prognosis.
Genes Chromosomes Cancer,
19,
22-28
(1997).
10.1002/(SICI)1098-2264(199705)19:1<22::AID-GCC4>3.0.CO;2-2 CAS PubMed Web of Science® Google Scholar
- Tamura, M., Gu, J., Matsumoto, K., Aota, S., Parsons, R. and Yamada, K.M., Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN. Science, 280, 1614-1617 (1998).
- Tsao, H., Zhang, X., Benoit, E. and Haluska, F.G., Identification of PTEN/MMAC1 alterations in uncultured melanomas and melanoma cell lines. Oncogene, 16, 3397-3402 (1998).
- Vlietstra, R.J., Van alewijk, D.C., Hermans, K.G., Van steenbrugge, G.J. and Trapman, J., Frequent inactivation of PTEN in prostate cancer cell lines and xenografts. Cancer Res., 58, 2720-2723 (1998).
-
Walker, G.J.,
Flores, J.F.,
Glendening, J.M.,
Lin, A.H.,
Markl, I.D. and
Fountain, J.W.,
Virtually 100% of melanoma cell lines harbor alterations at the DNA level within CDKN2A, CDKN2B, or one of their downstream targets.
Genes Chromosomes Cancer,
22,
157-163
(1998).
10.1002/(SICI)1098-2264(199806)22:2<157::AID-GCC11>3.0.CO;2-N CAS PubMed Web of Science® Google Scholar
- Wang, S.I., Puc, J., Li, J., Bruce, J.N., Cairns, P., Sidransky, D. and Parsons, R., Somatic mutations of PTEN in glioblastoma multiforme. Cancer Res., 57, 4183-4186 (1997).
- White, V.A., McNeil, B.K. and Horsman, D.E., Acquired homozygosity (isodisomy) of chromosome 3 in uveal melanoma. Cancer Genet. Cytogenet., 102, 40-45 (1998).
Citing Literature
